Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on September 9, 2004. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Q -- HRSA 340B Prime Vendor Agreement

Awarded
HRSA-232-BPHC-AG-01(4)Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 446110
Federal
Specialty Pharmacy Fulfillment of Lenalidomide (Revlimid)The contract involves the specialty pharmacy fulfillment and delivery of Lenalidomide (Revlimid), a medication used primarily in the treatment of certain cancers and blood disorders, to patients of the Department of Veterans Affairs (VA). The contractor is responsible for dispensing either branded or therapeutically equivalent versions of Lenalidomide in varying strengths. This service must comply with Risk Evaluation and Mitigation Strategies (REMS) protocols, ensuring safe and effective use of the medication. Essential contract activities include verifying prescriptions, conducting patient outreach to support medication adherence and understanding, securely packaging the medication, and ensuring delivery is confirmed by obtaining signatures upon receipt. This subcontract is issued by the 252-NETWORK Contract Office 12 under the Department of Veterans Affairs and aligns with NAICS code 446110, which typically covers pharmacies and drug stores. While specific performance location details and points of contact are not provided, the contract underscores the importance of compliance with federal safety standards and thorough patient management. The seamless coordination of prescription verification, patient communication, packaging, and secure delivery highlights the contractor’s critical role in supporting VA patients’ access to this specialized pharmaceutical therapy.
252-NETWORK Contract Office 12 (36C252)

POSTED

10 months ago

DEADLINE

N/A

General Info

Agency

N/A

Contract Value

$0

NAICS

446110 - Pharmacies and Drug Stores

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

2 updates
PhaseAwarded
Posted

Presolicitation

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Francis R MurphyContracting Officer

Full Description

Show more
The Health Resources and Services Administration (HRSA) intends to solicit proposals with the intent of signing an agreement with an organization having the capability to develop, maintain, and coordinate a prime vendor program in accordance with Section 340B of the Public Health Service Act, Public Law 102-585, - Limitation on Prices of Drugs Purchased by Covered Entities. Section 340B provides that drug manufacturers who sign a Pharmaceutical Pricing Agreement, as the manufacturers are required to do by Section 1927 (a) of the Social Security Act, with the Secretary of Health and Human Services agree to charge a price for covered outpatient drugs to covered entities that will not exceed the amount determined under a statutory formula (ceiling price). Section 340B also mandates the establishment of a prime vendor program. Consistent with this mandate, HRSA has developed a program which consists of both price negotiation and drug distribution for covered entities that elect to participate in the prime vendor program (member entities). The offer that submits a technically-acceptable responsive proposal that offers the best value to member entities will be selected as the Prime Vendor. The Prime Vendor shall operate as an independent entity and not as an agent of the Government. No Federal funds will be awarded to the Prime Vendor under this Agreement. The Prime Vendor shall provide, directly or by subcontract, all drug/pharmaceutical items authorized under Section 340B for distribution to all member entities. The Prime Vendor has the option to offer other catalog items, as appropriate. In addition, the Prime Vendor shall negotiate sub-ceiling prices for the benefit of the member entities. HRSA reserves the right not to award an Agreement if it is determined that no organization meets the technical and business criteria enumerated in the HRSA Request for Agreement. A Request for Agreement HRSA 232-BPHC-AG-01(4)FM is anticipated to be released within 60 days from release of this notice. Offerors will have sixty days from release of the Request for Agreement to submit their proposal. The solicitation will be available at this web site (www.fbo.gov) as an attachment to this announcement. It is the offeror's responsibility to monitor this site for amendments to this solicitation.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS